Pages that link to "Item:Q2391253"

The following pages link to A mathematical model of intermittent androgen suppression for prostate cancer (Q2391253):

Displaying 48 items.

• A nonlinear competitive model of the prostate tumor growth under intermittent androgen suppression (Q307599) (← links)
• A partial differential equation model and its reduction to an ordinary differential equation model for prostate tumor growth under intermittent hormone therapy (Q464772) (← links)
• A validated mathematical model of tumor growth including tumor-host interaction, cell-mediated immune response and chemotherapy (Q486657) (← links)
• Mathematical modeling of continuous and intermittent androgen suppression for the treatment of advanced prostate cancer (Q504676) (← links)
• Global dynamics of a model of joint hormone treatment with dendritic cell vaccine for prostate cancer (Q524063) (← links)
• Ability of intermittent androgen suppression to selectively create a non-trivial periodic orbit for a type of prostate cancer patients (Q739736) (← links)
• A nonlinear model with competition between prostate tumor cells and its application to intermittent androgen suppression therapy of prostate cancer (Q938707) (← links)
• Bifurcation analysis on a hybrid systems model of intermittent hormonal therapy for prostate cancer (Q957607) (← links)
• Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancer (Q1716254) (← links)
• Parameter identification of a model for prostate cancer treated by intermittent therapy (Q1716890) (← links)
• Periodic and chaotic dynamics in a map-based model of tumor-immune interaction (Q1790827) (← links)
• Threshold dynamics of a stochastic model of intermittent androgen deprivation therapy for prostate cancer (Q2025480) (← links)
• Intermittent hormone therapy models analysis and Bayesian model comparison for prostate cancer (Q2060027) (← links)
• Do mechanisms matter? Comparing cancer treatment strategies across mathematical models and outcome objectives (Q2092087) (← links)
• PCa dynamics with neuroendocrine differentiation and distributed delay (Q2092232) (← links)
• Dynamics of a non-smooth model of prostate cancer with intermittent androgen deprivation therapy (Q2104189) (← links)
• On tumoural growth and treatment under cellular dedifferentiation (Q2105497) (← links)
• Dynamic behavior of stochastic prostate cancer system with comprehensive therapy under regime switching (Q2110850) (← links)
• Dynamics and implications of models for intermittent androgen suppression therapy (Q2160560) (← links)
• Predictability and identifiability assessment of models for prostate cancer under androgen suppression therapy (Q2160715) (← links)
• Analysis of mathematical model of prostate cancer with androgen deprivation therapy (Q2206055) (← links)
• A time scales approach for modeling intermittent hormone therapy for prostate cancer (Q2211777) (← links)
• Modeling the effect of immunotherapies on human castration-resistant prostate cancer (Q2225975) (← links)
• Androgen driven evolutionary population dynamics in prostate cancer growth (Q2230326) (← links)
• Practically scheduling hormone therapy for prostate cancer using a mathematical model (Q2317045) (← links)
• Optimal design of personalized prostate cancer therapy using infinitesimal perturbation analysis (Q2406966) (← links)
• Comparison between mathematical models of intermittent androgen suppression for prostate cancer (Q2415738) (← links)
• Avoiding healthy cells extinction in a cancer model (Q2632759) (← links)
• A new protocol for intermittent androgen suppression therapy of prostate cancer with unstable saddle-point dynamics (Q2632781) (← links)
• Stationary distribution and persistence of a stochastic mathematical model for prostate cancer with pulsed therapy (Q2691976) (← links)
• Parameter estimation and optimal scheduling algorithm for a mathematical model of intermittent androgen suppression therapy for prostate cancer (Q2787900) (← links)
• Dynamical Aspects of a Hybrid System Describing Intermittent Androgen Suppression Therapy of Prostate Cancer (Q2832797) (← links)
• Dynamics of an HBV Model with Drug Resistance Under Intermittent Antiviral Therapy (Q2944477) (← links)
• Combination of singularly perturbed vector field method and method of directly defining the inverse mapping applied to complex ODE system prostate cancer model (Q3300970) (← links)
• A MODEL AT THE MACROSCOPIC SCALE OF PROSTATE TUMOR GROWTH UNDER INTERMITTENT ANDROGEN SUPPRESSION (Q3400124) (← links)
• Method of directly defining the inverse mapping applied to prostate cancer immunotherapy — Mathematical model (Q4578273) (← links)
• Stability analysis on a hybrid PDE–ODE system describing intermittent hormonal therapy of prostate cancer (Q4603532) (← links)
• The Impact of Fractional Differentiation in Terms of Fitting for a Prostate Cancer Model Under Intermittent Androgen Suppression Therapy (Q4992720) (← links)
• Mathematical insights into neuroendocrine transdifferentiation of human prostate cancer cells (Q5029942) (← links)
• Bifurcation Analysis of Mathematical Model of Prostate Cancer with Immunotherapy (Q5116615) (← links)
• Hybrid optimal scheduling for intermittent androgen suppression of prostate cancer (Q5251346) (← links)
• Nonlinear systems identification by combining regression with bootstrap resampling (Q5264597) (← links)
• MATHEMATICAL MODELING OF PROSTATE TUMOR GROWTH UNDER INTERMITTENT ANDROGEN SUPPRESSION WITH PARTIAL DIFFERENTIAL EQUATIONS (Q5322609) (← links)
• A mathematical model of prostate tumor growth under hormone therapy with mutation inhibitor (Q5962228) (← links)
• Optimization therapy by coupling intermittent androgen suppression with impulsive chemotherapy for a prostate cancer model (Q6066157) (← links)
• Numerical convergence and stability analysis for a nonlinear mathematical model of prostate cancer (Q6066573) (← links)
• Selection of prostate cancer therapy strategy under early androgen suppression treatment (Q6199715) (← links)
• A joint-threshold Filippov model describing the effect of intermittent androgen-deprivation therapy in controlling prostate cancer (Q6648464) (← links)